Literature DB >> 15296730

Crystal structures of a ligand-free and malonate-bound human caspase-1: implications for the mechanism of substrate binding.

Michael J Romanowski1, Justin M Scheer, Tom O'Brien, Robert S McDowell.   

Abstract

Caspase-1, a mediator of the posttranslational processing of IL-1beta and IL-18, requires an aspartic acid in the P1 position of its substrates. The mechanisms of caspase-1 activation remain poorly understood despite numerous structures of the enzyme complexed with aspartate-based inhibitors. Here we report a crystal structure of ligand-free caspase-1 that displays dramatic rearrangements of loops defining the active site to generate a closed conformation that is incompatible with substrate binding. A structure of the enzyme complexed with malonate shows the protein in its open (active-site ligand-bound) conformation in which malonate reproduces the hydrogen bonding network observed in structures with covalent inhibitors. These results illustrate the essential function of the obligatory aspartate recognition element that opens the active site of caspase-1 to substrates and may be the determinant responsible for the conformational changes between ligand-free and -bound forms of the enzyme, and suggest a new approach for identifying novel aspartic acid mimetics.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15296730     DOI: 10.1016/j.str.2004.05.010

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  27 in total

Review 1.  Allosteric regulation of protease activity by small molecules.

Authors:  Aimee Shen
Journal:  Mol Biosyst       Date:  2010-06-10

Review 2.  The protein structures that shape caspase activity, specificity, activation and inhibition.

Authors:  Pablo Fuentes-Prior; Guy S Salvesen
Journal:  Biochem J       Date:  2004-12-01       Impact factor: 3.857

3.  Two-state selection of conformation-specific antibodies.

Authors:  Junjun Gao; Sachdev S Sidhu; James A Wells
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-10       Impact factor: 11.205

Review 4.  Current knowledge on procaspase-1 variants with reduced or abrogated enzymatic activity in autoinflammatory disease.

Authors:  Hella Luksch; Stefan Winkler; Michael C Heymann; Felix Schulze; Sigrun R Hofmann; Joachim Roesler; Angela Rösen-Wolff
Journal:  Curr Rheumatol Rep       Date:  2015-07       Impact factor: 4.592

5.  A designed redox-controlled caspase.

Authors:  Witold A Witkowski; Jeanne A Hardy
Journal:  Protein Sci       Date:  2011-08       Impact factor: 6.725

6.  A common allosteric site and mechanism in caspases.

Authors:  Justin M Scheer; Michael J Romanowski; James A Wells
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-08       Impact factor: 11.205

Review 7.  Small Molecule Active Site Directed Tools for Studying Human Caspases.

Authors:  Marcin Poreba; Aleksandra Szalek; Paulina Kasperkiewicz; Wioletta Rut; Guy S Salvesen; Marcin Drag
Journal:  Chem Rev       Date:  2015-11-09       Impact factor: 60.622

8.  Solution structure of Archaeglobus fulgidis peptidyl-tRNA hydrolase (Pth2) provides evidence for an extensive conserved family of Pth2 enzymes in archea, bacteria, and eukaryotes.

Authors:  Robert Powers; Nebojsa Mirkovic; Sharon Goldsmith-Fischman; Thomas B Acton; Yiwen Chiang; Yuanpeng J Huang; Lichung Ma; P K Rajan; John R Cort; Michael A Kennedy; Jinfeng Liu; Burkhard Rost; Barry Honig; Diana Murray; Gaetano T Montelione
Journal:  Protein Sci       Date:  2005-11       Impact factor: 6.725

9.  Substrate and inhibitor-induced dimerization and cooperativity in caspase-1 but not caspase-3.

Authors:  Debajyoti Datta; Christopher L McClendon; Matthew P Jacobson; James A Wells
Journal:  J Biol Chem       Date:  2013-02-05       Impact factor: 5.157

10.  Crystal structure of procaspase-1 zymogen domain reveals insight into inflammatory caspase autoactivation.

Authors:  J Michael Elliott; Lionel Rouge; Christian Wiesmann; Justin M Scheer
Journal:  J Biol Chem       Date:  2008-12-30       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.